Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
01/09/2007 | US7160889 Quinazoline compounds |
01/09/2007 | US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
01/09/2007 | US7160874 Phenylalanine derivatives |
01/09/2007 | US7160724 Cells for use in the treatment of nervous system disorders |
01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
01/09/2007 | CA2333427C Foaming composition for hair care |
01/09/2007 | CA2315246C Topical compositions for enhancing glutathione production |
01/09/2007 | CA2184262C Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
01/09/2007 | CA2176511C Biologically active silicon compounds and their therapeutic and cosmetic applications |
01/09/2007 | CA2169831C Cosmetic melanins |
01/04/2007 | WO2007002447A2 Compositions for treating rosacea |
01/04/2007 | WO2007000619A1 Use of a mixture of superoxide dismutase and catalase for treating inflammatory skin lesions |
01/04/2007 | WO2007000192A1 Topical compositions comprising nanoparticles of an isoflavone |
01/04/2007 | WO2007000004A1 Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
01/04/2007 | WO2006117660A3 Method for treating cancer, coronary, inflammatory and macular disease, combining the modulation of zinc- and/or copper dependent proteins |
01/04/2007 | WO2006106220A3 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
01/04/2007 | US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
01/04/2007 | US20070004806 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
01/04/2007 | US20070004788 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
01/04/2007 | US20070004739 Condensed polycyclic compounds |
01/04/2007 | US20070004726 4-[2-(3-tert-Butyl-4-diethylaminophenyl)-2-hydroxyiminoethoxy]benzoic acid; modulates nuclear retinoic acid receptors; suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or into cosmetic compositions |
01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
01/04/2007 | US20070004705 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
01/04/2007 | US20070004678 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
01/04/2007 | US20070004668 Antisense permeation enhancers |
01/04/2007 | US20070004633 Administering a peptide containing Gly-His-Lys conjugated to an alkanoic acid, lipoic acid or its reduced form, dihydrolipoic acid, N-lipoyllysine or retinoic acid to stimulate hair growth or stop hair loss; may be mixed with a sunscreen |
01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
01/04/2007 | US20070003510 Preparations containing an extract of eperua falcata and/or constituents of the latter |
01/04/2007 | DE202006016706U1 Composition for treating dry, stressed or wounded and radiation-damaged skin comprises canola oil, thistle oil, sesame oil and grapefruit oil |
01/04/2007 | DE102005028590A1 Cosmetic preparation in the form of an oil-in-water emulsion, useful as sun protecting agent, comprises isotridecylisononanoate, lipids, oil-in-water emulsifying agents and water-in-oil emulsifying agents and UV filter substances |
01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
01/03/2007 | EP1738742A2 Benzyl-1,3-thiazolidine-2,4-dione compounds, compositions comprising them and use for stimulating or inducing the growth of keratinic fibres and/or for diminsihing their loss |
01/03/2007 | EP1737538A1 Topical depigmenting formulations comprising an extract of bellis perennis |
01/03/2007 | EP1737491A2 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS |
01/03/2007 | EP1737477A2 Methods of use of probiotic lactobacilli for companion animals |
01/03/2007 | EP1737467A1 Method and composition for treatment of skin conditions |
01/03/2007 | EP1737457A2 Use of a sphingoid base associated with nicotinic acid or a nicotinic acid amide in the form of a depigmentation agent |
01/03/2007 | EP1737452A1 Angiogenesis-affecting compounds and methods of use thereof |
01/03/2007 | EP1737439A2 Calcium salts for the treatment of psoriasis, dermatitis and dandruff |
01/03/2007 | EP1641466B1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
01/03/2007 | EP1448208B1 Composition based on diosgenin ester for topical use |
01/03/2007 | EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
01/03/2007 | EP1411889B1 Cream for treatment of skin injured by the sun |
01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
01/03/2007 | EP1377315B1 Pharmaceutical compositions of rapmycins |
01/03/2007 | EP1355626B1 Veterinary dermatologic composition |
01/03/2007 | EP1343459B1 Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least one isoflavonoid |
01/03/2007 | EP1334124B1 Diastereomeric peptides and pharmaceutical compositions comprising them |
01/03/2007 | EP1328319B1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
01/03/2007 | EP1071440B1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
01/03/2007 | CN1890220A A crystalline of the salt form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
01/03/2007 | CN1889965A Use of biocompatible polymers for the preparation of a composition or a medical device |
01/03/2007 | CN1887324A Chinese composition and its prepn process and quality control method |
01/03/2007 | CN1887320A Chinese medicine for treating burns and scalds |
01/03/2007 | CN1887314A Chinese medicine composition and its prepn process and quality control method |
01/03/2007 | CN1887308A Medicine for treating tinea manuum and tinea pedis and prepn of medicine cream |
01/03/2007 | CN1887299A Pus drawing out ointment of pearl and cunxiang |
01/03/2007 | CN1887295A Medicine for promoting healing of wound |
01/03/2007 | CN1887286A Stable medicine composition of setastine or its salt |
01/03/2007 | CN1887280A Application of saturated fatty polyol or alcoholic acid as cross-linking agent in filming gel composition |
01/03/2007 | CN1887252A 皮肤用组成物 Skin composition |
01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
01/03/2007 | CN1293065C Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
01/03/2007 | CN1293034C New gamma selective retinoids |
01/03/2007 | CN1292802C Therapeutical solution for nuring wound and dressing material used with the theraputical solution |
01/03/2007 | CN1292774C Externally applied medicine for treating dermatosis |
01/03/2007 | CN1292773C Psoriasis treatment liquid |
01/03/2007 | CN1292771C Skin injury treating Chinese traditional medicine |
01/03/2007 | CN1292759C Treatment of chronic inflammatory diseases with CM 101/GBS toxin |
01/03/2007 | CN1292751C Imiquimod or its derivative liposome for local skin and its preparing method and use |
01/02/2007 | US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents |
01/02/2007 | US7157487 Vla-4 inhibitors |
01/02/2007 | US7157466 Quinazoline ditosylate salt compounds |
01/02/2007 | US7157465 Adenine derivatives |
01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
01/02/2007 | US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders |
01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
01/02/2007 | CA2445677C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |